Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

NCT00592969 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

164

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: metformin
DRUG: biphasic insulin aspart

Sponsor

Novo Nordisk A/S